PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer
Clinical trial NCT06933251 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06933251
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-20
- Primary completion
- 2030-02-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.